Expanded use of exenatide in the management of type 2 diabetes

dc.contributor.authorJohn, Linda E. ++
dc.contributor.authorKane, Michael P.
dc.contributor.authorBusch, Robert S.
dc.contributor.authorHamilton, Robert A.
dc.date.accessioned2023-11-21T20:17:16Z
dc.date.available2023-11-21T20:17:16Z
dc.date.issued2007
dc.descriptionClick on the Resource Link to access the article (may not be free).
dc.description.urihttps://doi.org/10.2337/diaspect.20.1.59
dc.identifier.citationLinda E. John, Michael P. Kane, Robert S. Busch, Robert A. Hamilton; Expanded Use of Exenatide in the Management of Type 2 Diabetes. Diabetes Spectr 1 January 2007; 20 (1): 59–63. https://doi.org/10.2337/diaspect.20.1.59
dc.identifier.issn1040-9165
dc.identifier.urihttps://hdl.handle.net/20.500.14303/407
dc.language.isoen
dc.publisherAmerican Diabetes Association
dc.relation.ispartofDiabetes Spectrum
dc.rightsThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). http://rightsstatements.org/vocab/InC/1.0/
dc.subjectExenatide
dc.subjecttype 2 diabetes
dc.titleExpanded use of exenatide in the management of type 2 diabetes
dc.typeArticle
local.departmentprogramDepartment of Pharmacy Practice
Files